{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:17:24Z","timestamp":1790176644723,"version":"4.1.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.mam.2024.101280","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:36:00Z","timestamp":1718170560000},"page":"101280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Hippo signaling modulation and its biological implications in urological malignancies"],"prefix":"10.1016","volume":"98","author":[{"given":"Tongyu","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiliang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-9415","authenticated-orcid":false,"given":"Jun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2024.101280_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.14598","article-title":"MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3","author":"Asai","year":"2023","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/path.5781","article-title":"Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer","volume":"255","author":"Asrani","year":"2021","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051850","article-title":"Transcriptional profiling of advanced urothelial cancer predicts prognosis and response to immunotherapy","volume":"21","author":"Baek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2024.101280_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104092","article-title":"YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer","volume":"81","author":"Baek","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib5","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gkaa271","article-title":"IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway","volume":"48","author":"Bainbridge","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41580-022-00465-y","article-title":"Apical-basal polarity and the control of epithelial form and function","volume":"23","author":"Buckley","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20136","key":"10.1016\/j.mam.2024.101280_bib9","first-page":"461","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomarkers"},{"issue":"11","key":"10.1016\/j.mam.2024.101280_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144108","article-title":"Deletion of Lats1\/2 in adult kidney epithelia leads to renal cell carcinoma","volume":"131","author":"Carter","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188809","article-title":"microRNA-205 in prostate cancer: overview to clinical translation","volume":"1877","author":"Chauhan","year":"2022","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"7051","key":"10.1016\/j.mam.2024.101280_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib14","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3892\/ijo.2014.2687","article-title":"Methylation-associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma","volume":"45","author":"Chen","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mam.2024.101280_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13131","article-title":"Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib16","article-title":"Pan-urologic cancer genomic subtypes that transcend tissue of origin","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/carcin\/bgac014","article-title":"YAP1 activation promotes epithelial-mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress","volume":"43","author":"Chen","year":"2022","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.mam.2024.101280_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41419-023-05970-2","article-title":"PLAGL2 promotes bladder cancer progression via RACGAP1\/RhoA GTPase\/YAP1 signaling","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage","volume":"35","author":"Ciamporcero","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.mam.2024.101280_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2017.12.005","article-title":"Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer","volume":"115","author":"Ciamporcero","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.mam.2024.101280_bib21","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1038\/sj.emboj.7601872","article-title":"The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1","volume":"26","author":"Cinar","year":"2007","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib22","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1158\/0008-5472.CAN-10-4532","article-title":"MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling","volume":"71","author":"Cinar","year":"2011","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.mam.2024.101280_bib23","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1074\/jbc.RA120.013794","article-title":"Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity","volume":"295","author":"Cinar","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.mam.2024.101280_bib24","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M112.358713","article-title":"Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase\/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1","volume":"287","author":"Collak","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12253-019-00634-z","article-title":"YAP1 is involved in tumorigenic properties of prostate cancer cells","volume":"26","author":"Collak","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.mam.2024.101280_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.freeradbiomed.2019.06.009","article-title":"Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells","volume":"141","author":"Cucci","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mam.2024.101280_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","article-title":"Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism","volume":"150","author":"Cucci","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mam.2024.101280_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pathol-012513-104703","article-title":"Origins of bladder cancer","volume":"11","author":"Czerniak","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nm.4378","article-title":"Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4","volume":"23","author":"Dai","year":"2017","journal-title":"Nat. Med."},{"issue":"26","key":"10.1016\/j.mam.2024.101280_bib30","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling Axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"7279","key":"10.1016\/j.mam.2024.101280_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.mam.2024.101280_bib32","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.7150\/jca.63514","article-title":"Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP","volume":"13","author":"Dan","year":"2022","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib33","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1038\/s41598-018-36456-3","article-title":"ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer","volume":"9","author":"Di Martino","year":"2019","journal-title":"Sci. Rep."},{"issue":"7333","key":"10.1016\/j.mam.2024.101280_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature09677","article-title":"SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression","volume":"470","author":"Ding","year":"2011","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.mam.2024.101280_bib35","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1200\/JCO.19.00811","article-title":"Predictive significance of androgen receptor splice variant 7 in patients with metastatic castration-resistant prostate cancer: the PROPHECY study","volume":"37","author":"Dirix","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7150\/ijms.23460","article-title":"Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway","volume":"15","author":"Dong","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jcmm.17632","article-title":"Heterogeneity of Hippo signalling activity in different histopathologic subtypes of renal cell carcinoma","volume":"27","author":"Duong","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","article-title":"Global burden of urologic cancers, 1990-2013","volume":"71","author":"Dy","year":"2017","journal-title":"Eur. Urol."},{"issue":"5\u20136","key":"10.1016\/j.mam.2024.101280_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/15384047.2021.1919004","article-title":"Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism","volume":"22","author":"Elbadawy","year":"2021","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","article-title":"The potential of MicroRNAs as prostate cancer biomarkers","volume":"70","author":"Fabris","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mam.2024.101280_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-023-00579-1","article-title":"Insights into recent findings and clinical application of YAP and TAZ in cancer","author":"Franklin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157171","article-title":"YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma","volume":"133","author":"Frost","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib44","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.3390\/ijms150915173","article-title":"Curcumin promotes KLF5 proteasome degradation through downregulating YAP\/TAZ in bladder cancer cells","volume":"15","author":"Gao","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nyas.14358","article-title":"Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection","volume":"1473","author":"Ghasemi","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib46","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1038\/s41467-018-05939-2","article-title":"A feed forward loop enforces YAP\/TAZ signaling during tumorigenesis","volume":"9","author":"Gill","year":"2018","journal-title":"Nat. Commun."},{"issue":"5991","key":"10.1016\/j.mam.2024.101280_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.1189992","article-title":"Identification of a cell of origin for human prostate cancer","volume":"329","author":"Goldstein","year":"2010","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.mam.2024.101280_bib48","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41388-020-1272-x","article-title":"Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis","volume":"39","author":"Goto","year":"2020","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib49","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/cr.2013.120","article-title":"A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity","volume":"23","author":"Guo","year":"2013","journal-title":"Cell Res."},{"issue":"45","key":"10.1016\/j.mam.2024.101280_bib50","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/onc.2017.240","article-title":"miR-302\/367\/LATS2\/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"issue":"527","key":"10.1016\/j.mam.2024.101280_bib51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2021.12.019","article-title":"Context-dependent transcriptional regulations of YAP\/TAZ in cancer","volume":"28","author":"Guo","year":"2022","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41388-020-01548-w","article-title":"FRMD6 has tumor suppressor functions in prostate cancer","volume":"40","author":"Haldrup","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.mam.2024.101280_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-023-01824-9","article-title":"Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts","volume":"22","author":"He","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib56","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41467-023-37871-5","article-title":"LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism","volume":"14","author":"He","year":"2023","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.mam.2024.101280_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302228","article-title":"Downregulation of YAP activity restricts P53 hyperactivation to promote cell survival in confinement","volume":"10","author":"Hemmati","year":"2023","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrendo.2016.70","article-title":"Control of puberty onset and fertility by gonadotropin-releasing hormone neurons","volume":"12","author":"Herbison","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mam.2024.101280_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153210","article-title":"Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling","volume":"69","author":"Huang","year":"2020","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00204-020-02663-z","article-title":"Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population","volume":"94","author":"Huang","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib61","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00011-021-01494-7","article-title":"Bladder mesenchymal stromal cell-derived exosomal miRNA-217 modulates bladder cancer cell survival through Hippo-YAP pathway","volume":"70","author":"Huang","year":"2021","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3322\/canjclin.22.4.232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-20-3506","article-title":"Checking the hippo in sarcomatoid renal cell carcinoma with immunotherapy","volume":"27","author":"Hwang","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ph12040181","article-title":"Prostate-derived ETS factor (PDEF) modulates yes associated protein 1 (YAP1) in prostate cancer cells: a potential cross-talk between PDEF and hippo signaling","volume":"12","author":"Jaiswal","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"21","key":"10.1016\/j.mam.2024.101280_bib65","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/onc.2014.206","article-title":"In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth","volume":"34","author":"Jiang","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib66","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41467-019-09233-7","article-title":"MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression","volume":"10","author":"Jiang","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s13577-021-00538-8","article-title":"S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway","volume":"34","author":"Jiang","year":"2021","journal-title":"Hum. Cell"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib68","first-page":"3783","article-title":"YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells","volume":"17","author":"Jin","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib69","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1080\/21691401.2019.1648281","article-title":"Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer","volume":"47","author":"Jin","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib70","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1158\/0008-5472.CAN-22-1693","article-title":"YAP-activated SATB2 is a coactivator of NRF2 that amplifies antioxidative capacity and promotes tumor progression in renal cell carcinoma","volume":"83","author":"Jin","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib71","article-title":"Metabolic modulation of intracellular ammonia via intravesical instillation of nanoporter-encased hydrogel eradicates bladder carcinoma","volume":"10","author":"Jing","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/path.4706","article-title":"Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway","volume":"239","author":"Kai","year":"2016","journal-title":"J. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.mam.2024.101280_bib73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-019-03648-y","article-title":"RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target","volume":"464","author":"Khandelwal","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib74","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI78132","article-title":"Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib75","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3892\/or.2016.4747","article-title":"ETS transcription factor ERG cooperates with histone demethylase KDM4A","volume":"35","author":"Kim","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188625","article-title":"miRNAs and androgen deprivation therapy for prostate cancer","volume":"1876","author":"Konoshenko","year":"2021","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib77","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.devcel.2013.04.021","article-title":"The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression","volume":"25","author":"Koontz","year":"2013","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-021-01870-5","article-title":"Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. J Exp","volume":"40","author":"Kumar","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib79","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4161\/epi.27957","article-title":"Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression","volume":"9","author":"Kuser-Abali","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.mam.2024.101280_bib80","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1038\/ncomms9126","article-title":"YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer","volume":"6","author":"Kuser-Abali","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040295","article-title":"CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling","volume":"8","author":"Lai","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2013.12.019","article-title":"Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer","volume":"66","author":"Lamoureux","year":"2014","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13046-020-01723-7","article-title":"Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition","volume":"39","author":"Lannelli","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib84","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1007\/s00018-021-03781-2","article-title":"Context-dependent roles of YAP\/TAZ in stem cell fates and cancer","volume":"78","author":"LeBlanc","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"13","key":"10.1016\/j.mam.2024.101280_bib85","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41388-021-01718-4","article-title":"YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer","volume":"40","author":"Lee","year":"2021","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib86","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41388-021-02131-7","article-title":"Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP\/TAZ inhibition","volume":"41","author":"Lee","year":"2022","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.mam.2024.101280_bib87","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","article-title":"Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus","volume":"140","author":"Li","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib89","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-10-3268","article-title":"Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib90","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ccr.2014.02.007","article-title":"SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer","volume":"25","author":"Li","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.devcel.2014.09.012","article-title":"The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila","volume":"31","author":"Li","year":"2014","journal-title":"Dev. Cell"},{"issue":"18","key":"10.1016\/j.mam.2024.101280_bib92","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1111\/jcmm.15653","article-title":"Glucose promotes epithelial-mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib93","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.7150\/thno.56604","article-title":"MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-022-00465-4","article-title":"The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth","volume":"8","author":"Li","year":"2022","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib95","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-022-30831-5","article-title":"YAP inhibits ER\u03b1 and ER+ breast cancer growth by disrupting a TEAD-ER\u03b1 signaling axis","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib96","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112184","article-title":"YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth","volume":"42","author":"Li","year":"2023","journal-title":"EMBO J."},{"issue":"13","key":"10.1016\/j.mam.2024.101280_bib97","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.121173298","article-title":"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor","volume":"98","author":"Lin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib98","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/or.2020.7616","article-title":"TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells","volume":"44","author":"Lin","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mam.2024.101280_bib99","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2407-13-349","article-title":"Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2016.05.010","article-title":"Phosphodiesterase 5\/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway","volume":"378","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.mam.2024.101280_bib101","doi-asserted-by":"crossref","first-page":"9420","DOI":"10.1074\/jbc.M117.783787","article-title":"ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer","volume":"292","author":"Liu","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib102","doi-asserted-by":"crossref","first-page":"e3022","DOI":"10.1038\/cddis.2017.396","article-title":"Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib103","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745180","article-title":"PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin beta 2 expression","volume":"19","author":"Liu","year":"2018","journal-title":"EMBO Rep."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib104","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1002\/jcb.27284","article-title":"Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib105","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.18632\/aging.103300","article-title":"Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498\/YAP1 axis","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"23","key":"10.1016\/j.mam.2024.101280_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300708","article-title":"Transforming growth factor beta promotes inflammation and tumorigenesis in smad4-deficient intestinal epithelium in a YAP-dependent manner","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"issue":"7647","key":"10.1016\/j.mam.2024.101280_bib107","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature21676","article-title":"Effective combinatorial immunotherapy for castration-resistant prostate cancer","volume":"543","author":"Lu","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib108","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12935-021-02095-4","article-title":"MINDY1 promotes bladder cancer progression by stabilizing YAP","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib109","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13046-023-02704-2","article-title":"New insights into the ambivalent role of YAP\/TAZ in human cancers","volume":"42","author":"Luo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.eururo.2013.12.003","article-title":"Long noncoding RNA in prostate, bladder, and kidney cancer","volume":"65","author":"Martens-Uzunova","year":"2014","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib111","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12885-020-06844-y","article-title":"Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer","volume":"20","author":"Matsuda","year":"2020","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.mam.2024.101280_bib112","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/pros.24226","article-title":"Pathological significance and prognostic role of LATS2 in prostate cancer","volume":"81","author":"Matsuda","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.mam.2024.101280_bib113","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-11-523","article-title":"Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma","volume":"11","author":"Matsuura","year":"2011","journal-title":"BMC Cancer"},{"issue":"49","key":"10.1016\/j.mam.2024.101280_bib114","doi-asserted-by":"crossref","first-page":"16897","DOI":"10.1074\/jbc.AC120.014698","article-title":"Naturally occurring hotspot cancer mutations in Galpha(13) promote oncogenic signaling","volume":"295","author":"Maziarz","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/erc.0.0110281","article-title":"Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain","volume":"11","author":"McEwan","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"issue":"8472","key":"10.1016\/j.mam.2024.101280_bib116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(86)90715-4","article-title":"Patterns of progression in prostate cancer","volume":"1","author":"McNeal","year":"1986","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.mam.2024.101280_bib117","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-16-0267","article-title":"Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney","volume":"6","author":"Mehra","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2024.101280_bib118","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1038\/ncomms9357","article-title":"MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway","volume":"6","author":"Meng","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib119","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cac2.12413","article-title":"N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2\/YAP axis-regulated Hippo pathway","volume":"43","author":"Miao","year":"2023","journal-title":"Cancer Commun."},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PAS.0b013e318206b67b","article-title":"ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib121","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1002\/jcb.27774","article-title":"MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A","volume":"120","author":"Mu","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib122","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: histological classification and correlation with imaging findings","volume":"48","author":"Muglia","year":"2015","journal-title":"Radiol. Bras."},{"issue":"25","key":"10.1016\/j.mam.2024.101280_bib123","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1038\/onc.2013.294","article-title":"Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2","volume":"33","author":"Mukhopadhyay","year":"2014","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.mam.2024.101280_bib124","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","article-title":"WNT signalling in prostate cancer","volume":"14","author":"Murillo-Garzon","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccell.2015.05.005","article-title":"ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors","volume":"27","author":"Nguyen","year":"2015","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.mam.2024.101280_bib126","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1089\/scd.2021.0043","article-title":"Reduced DAPK1 expression promotes stem cell-like characteristics of prostate cancer cells by activating ZEB1 via hippo\/YAP signaling pathway","volume":"30","author":"Nong","year":"2021","journal-title":"Stem Cell. Dev."},{"issue":"7","key":"10.1016\/j.mam.2024.101280_bib127","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.bjc.6690835","article-title":"Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study","volume":"81","author":"Norrish","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib128","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1158\/0008-5472.CAN-17-0836","article-title":"YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells","volume":"78","author":"Ooki","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev. Cell"},{"issue":"7702","key":"10.1016\/j.mam.2024.101280_bib130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib131","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/jca.28662","article-title":"Overexpression of FZD1 is associated with a good prognosis and resistance of sunitinib in clear cell renal cell carcinoma","volume":"10","author":"Peng","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2016.10.034","article-title":"Characterization of hippo pathway components by gene inactivation","volume":"64","author":"Plouffe","year":"2016","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib133","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1210\/me.2004-0065","article-title":"The LATS2\/KPM tumor suppressor is a negative regulator of the androgen receptor","volume":"18","author":"Powzaniuk","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mam.2024.101280_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.728663","article-title":"Monitoring spontaneous quiescence and asynchronous proliferation-quiescence decisions in prostate cancer cells","volume":"9","author":"Pulianmackal","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.03.027","article-title":"WWC proteins mediate LATS1\/2 activation by Hippo kinases and imply a tumor suppression strategy","volume":"82","author":"Qi","year":"2022","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.mam.2024.101280_bib136","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112126","article-title":"Two Hippo signaling modules orchestrate liver size and tumorigenesis","volume":"42","author":"Qi","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.mam.2024.101280_bib137","doi-asserted-by":"crossref","first-page":"12205","DOI":"10.2147\/CMAR.S273442","article-title":"YAP triggers bladder cancer proliferation by affecting the MAPK pathway","volume":"12","author":"Qiu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.mam.2024.101280_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12692","article-title":"A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells","volume":"7","author":"Qu","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib139","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/annonc\/mdx283","article-title":"Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide","volume":"28","author":"Rathkopf","year":"2017","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184590","article-title":"Mapping the STK4\/Hippo signaling network in prostate cancer cell","volume":"12","author":"Ready","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib141","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"Rebello","year":"2021","journal-title":"Prostate cancer. Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.mam.2024.101280_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12309","article-title":"A critical role for NF2 and the Hippo pathway in branching morphogenesis","volume":"7","author":"Reginensi","year":"2016","journal-title":"Nat. Commun."},{"issue":"9669","key":"10.1016\/j.mam.2024.101280_bib143","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib144","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrurol.2012.10","article-title":"Clinical potential of the ERG oncoprotein in prostate cancer","volume":"9","author":"Rosen","year":"2012","journal-title":"Nat. Rev. Urol."},{"issue":"27","key":"10.1016\/j.mam.2024.101280_bib145","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1200\/JCO.2011.35.1916","article-title":"Common gene rearrangements in prostate cancer","volume":"29","author":"Rubin","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib146","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"10305","key":"10.1016\/j.mam.2024.101280_bib147","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib148","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2016.12.010","article-title":"Prostate-specific antigen response and eradication of androgen receptor amplification with high-dose testosterone in prostate cancer","volume":"71","author":"Schiff","year":"2017","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib149","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ymthe.2021.08.029","article-title":"Non-canonical role of Hippo tumor suppressor serine\/threonine kinase 3 STK3 in prostate cancer","volume":"30","author":"Schirmer","year":"2022","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrurol.2017.140","article-title":"Ethnicity and ERG frequency in prostate cancer","volume":"15","author":"Sedarsky","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib151","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/onc.2016.185","article-title":"A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer","volume":"36","author":"Selth","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib152","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2017.03.158","article-title":"Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP","volume":"486","author":"Seo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mam.2024.101280_bib153","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1038\/ncomms3976","article-title":"Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase","volume":"4","author":"Serrano","year":"2013","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166540","article-title":"YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts","volume":"1868","author":"Shen","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12894-016-0137-7","article-title":"Do African-American men need separate prostate cancer screening guidelines?","volume":"16","author":"Shenoy","year":"2016","journal-title":"BMC Urol."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib156","first-page":"709","article-title":"Nitidine Chloride inhibits cell proliferation and invasion via downregulation of YAP expression in prostate cancer cells","volume":"11","author":"Shi","year":"2019","journal-title":"Am. J Transl. Res."},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib157","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/gtc.12979","article-title":"N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1\/TAZ","volume":"27","author":"Shiraishi","year":"2022","journal-title":"Gene Cell."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib158","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.2011-0227","article-title":"Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies","volume":"17","author":"Shuch","year":"2012","journal-title":"Oncol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib159","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib160","first-page":"1705","article-title":"Effect of taurine on the proliferation, apoptosis and MST1\/Hippo signaling in prostate cancer cells. Transl","volume":"11","author":"Song","year":"2022","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib161","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/febs.13718","article-title":"KIBRA promotes prostate cancer cell proliferation and motility","volume":"283","author":"Stauffer","year":"2016","journal-title":"FEBS J."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib162","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.7150\/thno.23964","article-title":"A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma","volume":"8","author":"Sun","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.mam.2024.101280_bib164","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.2147\/OTT.S217041","article-title":"RASSF6 is downregulated in human bladder cancers and regulates doxorubicin sensitivity and mitochondrial membrane potential via the hippo signaling pathway","volume":"12","author":"Tan","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib165","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1111\/cas.15463","article-title":"Hippo pathway monomerizes STAT3 to regulate prostate cancer growth","volume":"113","author":"Tang","year":"2022","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib166","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1200\/JCO.1996.14.6.1756","article-title":"Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points","volume":"14","author":"Tannock","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib167","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(02)00824-3","article-title":"Salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines","volume":"110","author":"Tapon","year":"2002","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib168","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s12274-021-3753-9","article-title":"Smart nanocarriers as therapeutic platforms for bladder cancer","volume":"15","author":"Tong","year":"2021","journal-title":"Nano Res."},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib169","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846570","article-title":"UBTD1 is a mechano-regulator controlling cancer aggressiveness","volume":"20","author":"Torrino","year":"2019","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mam.2024.101280_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/srep31842","article-title":"Molecular chaperone Hsp 27 regulates the Hippo tumor suppressor pathway in cancer","volume":"6","author":"Vahid","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib172","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102406","article-title":"Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor","volume":"39","author":"Vargas","year":"2020","journal-title":"EMBO J."},{"issue":"22","key":"10.1016\/j.mam.2024.101280_bib173","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1158\/0008-5472.CAN-16-1483","article-title":"alpha3beta1 integrin suppresses prostate cancer metastasis via regulation of the hippo pathway","volume":"76","author":"Varzavand","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib174","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","article-title":"Targeting YAP-dependent MDSC infiltration impairs tumor progression","volume":"6","author":"Wang","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-016-0556-9","article-title":"miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1","volume":"15","author":"Wang","year":"2016","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.mam.2024.101280_bib176","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrurol.2017.65","article-title":"The potential of organoids in urological cancer research","volume":"14","author":"Wang","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib177","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2018.10.088","article-title":"FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells","volume":"506","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib178","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/1078-0432.CCR-18-0586","article-title":"Targeting an autocrine regulatory loop in cancer stem-like cells impairs the progression and chemotherapy resistance of bladder cancer","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2024.101280_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102795","article-title":"SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression","volume":"56","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib180","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/15384101.2020.1748949","article-title":"Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539","volume":"19","author":"Wang","year":"2020","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib181","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41585-020-0314-z","article-title":"The diverse roles of SPOP in prostate cancer and kidney cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib182","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.mam.2024.101280_bib183","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1158\/0008-5472.CAN-22-3003","article-title":"WNT5a signaling through ROR2 activates the hippo pathway to suppress YAP1 activity and tumor growth","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib184","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajur.2019.11.001","article-title":"Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer","volume":"7","author":"Wen","year":"2020","journal-title":"Asian J Urol"},{"issue":"3","key":"10.1016\/j.mam.2024.101280_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2019.04.014","article-title":"YAP\/TAZ inhibition induces metabolic and signaling rewiring resulting in targetable vulnerabilities in NF2-deficient tumor cells","volume":"49","author":"White","year":"2019","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib187","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","article-title":"Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries","volume":"70","author":"Wong","year":"2016","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib188","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s13046-019-1346-1","article-title":"Metformin targets a YAP1-TEAD4 complex via AMPKalpha to regulate CCNE1\/2 in bladder cancer cells","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib189","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.3934\/mbe.2022432","article-title":"FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: a bioinformatics analysis of TAZ\/YAP","volume":"19","author":"Wu","year":"2022","journal-title":"Math. Biosci. Eng."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-023-01748-4","article-title":"Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib191","first-page":"132","article-title":"ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation","volume":"8","author":"Xiao","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.mam.2024.101280_bib192","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41418-022-00940-1","article-title":"IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis","volume":"29","author":"Xie","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib193","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","article-title":"CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.arcmed.2019.08.010","article-title":"YAP promotes VEGFA expression and tumor angiogenesis though Gli 2 in human renal cell carcinoma","volume":"50","author":"Xu","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.107","article-title":"The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma","volume":"28","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.mam.2024.101280_bib196","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","article-title":"The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma","volume":"28","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib197","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/1541-7786.MCR-20-0534","article-title":"The hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2","volume":"19","author":"Yang","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"21","key":"10.1016\/j.mam.2024.101280_bib198","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215448","article-title":"Prostate cancer stem cells: the role of CD133","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107617","article-title":"SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib200","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2013.08.025","article-title":"Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin\/NF2","volume":"154","author":"Yin","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib201","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13046-019-1344-3","article-title":"NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1\/2-YAP signaling","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mam.2024.101280_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.12.005","article-title":"SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo\/TEAD1-Twist 1 pathway","volume":"51","author":"Yin","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.mam.2024.101280_bib203","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2353\/ajpath.2009.080727","article-title":"NF-kappaB regulates androgen receptor expression and prostate cancer growth","volume":"175","author":"Zhang","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mam.2024.101280_bib204","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2016.21","article-title":"Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation","volume":"2","author":"Zhang","year":"2016","journal-title":"Cell Discov"},{"issue":"7686","key":"10.1016\/j.mam.2024.101280_bib205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mam.2024.101280_bib206","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/0008-5472.CAN-22-2801","article-title":"Deregulation of SPOP in cancer","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib207","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ceb.2008.10.001","article-title":"The Hippo-YAP pathway: new connections between regulation of organ size and cancer","volume":"20","author":"Zhao","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"14","key":"10.1016\/j.mam.2024.101280_bib208","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.mam.2024.101280_bib209","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1101\/gad.1909210","article-title":"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.mam.2024.101280_bib211","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919841235","article-title":"Gelsolin-like actin-capping protein has prognostic value and promotes tumorigenesis and epithelial-mesenchymal transition via the Hippo signaling pathway in human bladder cancer","volume":"11","author":"Zhaojie","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2024.101280_bib212","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.devcel.2015.08.014","article-title":"Identification of happyhour\/MAP4K as alternative hpo\/mst-like kinases in the hippo kinase cascade","volume":"34","author":"Zheng","year":"2015","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.mam.2024.101280_bib213","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-022-04865-y","article-title":"RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway","volume":"13","author":"Zhong","year":"2022","journal-title":"Cell Death Dis."},{"issue":"20","key":"10.1016\/j.mam.2024.101280_bib214","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.scib.2023.08.048","article-title":"Reconstructing the Hippo signaling network","volume":"68","author":"Zhong","year":"2023","journal-title":"Sci. Bull."},{"issue":"1","key":"10.1016\/j.mam.2024.101280_bib215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13046-017-0609-y","article-title":"Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3\/aPKC\/KIBRA complex and inactivating the hippo pathway","volume":"36","author":"Zhou","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.mam.2024.101280_bib216","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41388-018-0580-x","article-title":"Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"issue":"41","key":"10.1016\/j.mam.2024.101280_bib217","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1038\/s41388-021-02000-3","article-title":"P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis","volume":"40","author":"Zhu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.mam.2024.101280_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.616768","article-title":"Silencing of lncRNA MIR497HG via CRISPR\/Cas13d induces bladder cancer progression through promoting the crosstalk between hippo\/yap and TGF-beta\/smad signaling","volume":"7","author":"Zhuang","year":"2020","journal-title":"Front. Mol. Biosci."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T01:56:36Z","timestamp":1721440596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299724000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":215,"alternative-id":["S0098299724000396"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2024.101280","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hippo signaling modulation and its biological implications in urological malignancies","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2024.101280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101280"}}